Targeted Technology
Overview
Targeted Technology is a venture capital firm focused on early-stage investments in companies that advance ground-breaking or disruptive technologies to significantly improve the practice of medicine and patient outcomes. The firm favors technologies that improve the efficiency, cost, or functionality of the development and manufacture of life science products. It concentrates on technologies with the potential for a shorter time and lower cost to market, addressing market needs compelling enough to offer enhanced returns. The firm invests across a broad spectrum of healthcare categories, with an emphasis on medical devices, life science tools, biotechnology, diagnostics, and specialty pharmaceuticals.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Aerin Medical | Mar 2016 | Series C | Lead |
| Xenex | Jan 2015 | Series C | Co-investor |
| Xenex | Nov 2013 | Series B | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.